Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on April 13, 2005
J Am Soc Nephrol 16: 1266-1278, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004030222

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004030222v1
16/5/1266    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reich, H.
Right arrow Articles by Scholey, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reich, H.
Right arrow Articles by Scholey, J. W.

Cell Biology

Albumin Activates ERK Via EGF Receptor in Human Renal Epithelial Cells

Heather Reich*, David Tritchler{dagger}, Andrew M. Herzenberg{ddagger}, Zamaneh Kassiri§, Xiaohua Zhou||, Wei Gao|| and James W. Scholey*

* Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada; {dagger} Division of Epidemiology and Statistics, Ontario Cancer Institute, and University of Toronto, Toronto, Ontario, Canada; {ddagger} Department of Laboratory Medicine and Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada; and § Experimental Therapeutics, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; || Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Address correspondence to: Dr Heather Reich, University of Toronto, Medical Sciences Building, Clinical Science Division, Room 7326, 1 King’s College Circle, Toronto, ON M5S 1A8, Canada. Phone: 416-978-6870; Fax: 416-978-8765; h.reich{at}utoronto.ca

Received for publication March 23, 2004. Accepted for publication February 25, 2005.

Emerging clinical and experimental evidence strongly implicates proteinuria in the progression of kidney disease. One pathway involves the activation of NF{kappa}B by albumin, and it has been demonstrated that the activation of NF{kappa}B induced by albumin is dependent on mitogen-activated protein kinase ERK1/ERK2. To study the effect of albumin on gene expression, primary human renal tubular cells were exposed in vitro to albumin (1%) for 6 h, and gene expression profiling was performed with the human oligonucleotide microarray, U133A Affymetrix Gene Chip. In all, 223 genes were differentially regulated by albumin, including marked upregulation of the EGF receptor (EGFR) and IL-8. Accordingly, the authors sought to delineate the signaling pathway linking albumin to the EGFR and activation of ERK1/ERK2. It was found that albumin led to a dose- and time-dependent activation of ERK1/ERK2. Treatment with albumin led to EGFR phosphorylation, but the activation of ERK1/ERK2 was prevented by pretreatment of the cells with AG-1478, the EGFR kinase inhibitor, at a dose that inhibited EGF-induced ERK1/ERK2 activation. Exogenously administered reactive oxygen species (ROS) were found to activate ERK1/ERK2 via the EGFR and src tyrosine kinase activity and pretreatment of cells with the antioxidant N-acetylcysteine (NAC) and the NADPH oxidase inhibitor DPI abrogated albumin-induced activation of ERK1/ERK2. The src tyrosine kinase inhibitor, PP2, also inhibited the albumin-induced activation of ERK1/ERK2. Finally, pretreatment with AG-1478, the MEK inhibitor UO126, and NAC prevented the albumin-induced increase in IL-8 expression. The authors conclude that the EGF receptor plays a central role in the signaling pathway that links albumin to the activation of ERK1/ERK2 and increased expression of IL-8. Gene profiling studies suggest that there may be a positive feedback loop through the EGFR that amplifies the response of the proximal tubule cell to albumin. Taken together, these results suggest that the EGFR may be an important treatment target for kidney disease associated with proteinuria.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. M. van Timmeren, M.-L. Gross, W. Hanke, P. A. Klok, H. van Goor, C. A. Stegeman, and S. J. L. Bakker
Oleic acid loading does not add to the nephrotoxic effect of albumin in an amphibian and chronic rat model of kidney injury
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3814 - 3823.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. J. Lee and H. J. Han
Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-{kappa}B signal pathways in renal proximal tubule cells
Am J Physiol Renal Physiol, March 1, 2008; 294(3): F534 - F541.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. V. Arcidiacono, T. Sato, D. Alvarez-Hernandez, J. Yang, M. Tokumoto, I. Gonzalez-Suarez, Y. Lu, Y. Tominaga, J. Cannata-Andia, E. Slatopolsky, et al.
EGFR Activation Increases Parathyroid Hyperplasia and Calcitriol Resistance in Kidney Disease
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 310 - 320.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. N. Reich, S. Troyanov, J. W. Scholey, D. C. Cattran, and for the Toronto Glomerulonephritis Registry
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3177 - 3183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. W. Wong, G. Y. Oudit, H. Reich, Z. Kassiri, J. Zhou, Q. C. Liu, P. H. Backx, J. M. Penninger, A. M. Herzenberg, and J. W. Scholey
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Am. J. Pathol., August 1, 2007; 171(2): 438 - 451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Diwakar, A. L. Pearson, P. Colville-Nash, N. J. Brunskill, and M. E. C. Dockrell
The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1464 - F1470.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Chai and Z. Liu
p38 Mitogen-Activated Protein Kinase Mediates Palmitate-Induced Apoptosis But Not Inhibitor of Nuclear Factor-{kappa}B Degradation in Human Coronary Artery Endothelial Cells
Endocrinology, April 1, 2007; 148(4): 1622 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. S. Murali, A. W. Ackerman, A. J. Croatt, J. Cheng, J. P. Grande, S. L. Sutor, R. J. Bram, G. D. Bren, A. D. Badley, J. Alam, et al.
Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F837 - F844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. R. Hayden, N. A. Chowdhury, S. A. Cooper, A. Whaley-Connell, J. Habibi, L. Witte, C. Wiedmeyer, C. M. Manrique, G. Lastra, C. Ferrario, et al.
Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F861 - F867.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. M. Durkan, R. T. Alexander, G.-Y. Liu, M. Rui, G. Femia, and L. A. Robinson
Expression and Targeting of CX3CL1 (Fractalkine) in Renal Tubular Epithelial Cells
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 74 - 83.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Okada, T. Inoue, T. Kikuta, Y. Watanabe, Y. Kanno, S. Ban, T. Sugaya, M. Horiuchi, and H. Suzuki
A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade
Am. J. Pathol., November 1, 2006; 169(5): 1577 - 1589.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. C.W. Tang, J. C.K. Leung, L. Y.Y. Chan, A. W.L. Tsang, and K. N. Lai
Activation of Tubular Epithelial Cells in Diabetic Nephropathy and the Role of the Peroxisome Proliferator-Activated Receptor-{gamma} Agonist
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1633 - 1643.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP